UCB-FDA APPROVES EVENITY™ (ROMOSOZUMAB) FOR THE TREATMENT OF OSTEOPOROSIS IN POSTMENOP. (10.4.2019)

09 april 2019

Bijlagen

UCB-FDA APPROVE...